176.22
1.25%
-1.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Precedente Chiudi:
$178.10
Aprire:
$179.98
Volume 24 ore:
14,098
Relative Volume:
0.07
Capitalizzazione di mercato:
$5.12B
Reddito:
$241.52M
Utile/perdita netta:
$52.37M
Rapporto P/E:
-119.88
EPS:
-1.47
Flusso di cassa netto:
$58.06M
1 W Prestazione:
-0.85%
1M Prestazione:
-1.73%
6M Prestazione:
+5.42%
1 anno Prestazione:
+73.71%
Krystal Biotech Inc Stock (KRYS) Company Profile
Nome
Krystal Biotech Inc
Settore
Industria
Telefono
(412) 586-5830
Indirizzo
2100 WHARTON STREET, PITTSBURGH, PA
Confronta KRYS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
KRYS | 176.22 | 5.12B | 241.52M | 52.37M | 58.06M | -1.47 |
VRTX | 447.17 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 741.51 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.70 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 250.25 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 103.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-11-20 | Iniziato | Goldman | Buy |
2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
2023-10-12 | Iniziato | Citigroup | Buy |
2023-09-07 | Iniziato | Berenberg | Buy |
2023-04-18 | Iniziato | Stifel | Buy |
2023-02-28 | Aggiornamento | Goldman | Neutral → Buy |
2022-08-25 | Downgrade | Goldman | Buy → Neutral |
2022-01-18 | Iniziato | BofA Securities | Buy |
2021-07-20 | Aggiornamento | Goldman | Neutral → Buy |
2020-09-18 | Iniziato | B. Riley FBR | Buy |
2020-06-04 | Iniziato | Evercore ISI | Outperform |
2019-09-24 | Iniziato | Goldman | Neutral |
2019-08-06 | Reiterato | H.C. Wainwright | Buy |
2019-06-24 | Reiterato | Chardan Capital Markets | Buy |
2019-06-24 | Reiterato | H.C. Wainwright | Buy |
2019-05-30 | Iniziato | Guggenheim | Buy |
2018-09-11 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
Jennison Associates LLC Sells 110,333 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Segall Bryant & Hamill LLC Boosts Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
First Turn Management LLC Has $12.37 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Victory Capital Management Inc. - MarketBeat
Redmile Group, LLC Adjusts Stake in Krystal Biotech Inc - GuruFocus.com
Principal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
(KRYS) Proactive Strategies - Stock Traders Daily
FMR LLC's Strategic Acquisition of Krystal Biotech Inc Shares - GuruFocus.com
High Growth Tech Stocks Featuring Three Prominent US Companies - Simply Wall St
Krystal Biotech Inc (KRYS) Quarterly 10-Q Report - Quartzy
Krystal Biotech to Present at Stifel 2024 Healthcare Conference - StockTitan
Krystal Biotech, Inc. (NASDAQ:KRYS) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Raised by TimesSquare Capital Management LLC - MarketBeat
Janney Montgomery Scott LLC Buys 5,415 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Chardan Capital Predicts Lower Earnings for Krystal Biotech - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Simply Wall St
Q2 EPS Estimates for Krystal Biotech Raised by William Blair - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
HC Wainwright Predicts Reduced Earnings for Krystal Biotech - MarketBeat
HC Wainwright Forecasts Higher Earnings for Krystal Biotech - MarketBeat
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference - StockTitan
Krystal Biotech FY2024 EPS Forecast Raised by William Blair - MarketBeat
Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction - MSN
Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $206.00 at Citigroup - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from HC Wainwright - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Posts Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript - Insider Monkey
Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Krystal stock gains modest boost from Citi, but compliance risks linger - Investing.com Canada
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates - MSN
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Krystal Biotech Faces Challenges in Scaling VYJUVEK Production Amid Regulatory Hurdles - TipRanks
Earnings call: Krystal Biotech reports robust Q3 2024 results By Investing.com - Investing.com Nigeria
Krystal Biotech Reports Strong Q3 2024 Performance - TipRanks
Earnings call: Krystal Biotech reports robust Q3 2024 results - Investing.com India
Krystal Biotech (NASDAQ:KRYS) Shares Gap DownHere's Why - MarketBeat
Krystal Biotech earnings missed by $0.08, revenue topped estimates - Investing.com UK
Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times
Krystal Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock? - MSN
Where are the Opportunities in (KRYS) - Stock Traders Daily
Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Re - GuruFocus.com
Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Results - Yahoo Finance
Krystal Biotech (KRYS) Set to Announce Quarterly Earnings on Monday - MarketBeat
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth - MSN
Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 - The Manila Times
Hennion & Walsh Asset Management Inc. Cuts Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech Inc Azioni (KRYS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):